Trial Profile
A double-blind, placebo controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Oct 2005
Price :
$35
*
At a glance
- Drugs Sibutramine (Primary)
- Indications Obesity
- Focus Pharmacodynamics
- 27 Oct 2005 New trial record.